Jennifer Manne-Goehler, HIV clinician-scientist at the Brigham and Women's Hospital and Assistant Professor of Medicine at Harvard Medical School, talks to us about the cardiometabolic complications of HIV, specifically cardiovascular disease, diabetes, and weight loss strategies for people...
Drs Benjamin Levy III and Michael Camilleri discuss managing GLP-1 gastrointestinal adverse effects, preparing patients for endoscopy, and treating obesity.
Testosterone influences far more than just libido and muscle growth: In this episode, Dr. Jonathan Apasu speaks with Prof. Farid Saad about the crucial role of testosterone in metabolism, insulin resistance, prediabetes, diabetes, and obesity. Together, they explain why testosterone deficiency...
* Dr Saad says: “Long-term testosterone therapy in hypogonadal men resulted in profound and sustained in weight loss which may have contributed to reductions in mortality and cardiovascular events. Untreated men with hypogonadism gained weight.”
* Dr Saad says: “Long-term testosterone therapy...
32:00-44:15
Case: 54-Year-Old Man with Vaculogenic ED
Case Study: Body Composition Transformation
THE EFFECTS OF COMBINED THERAPY ON HORMONAL AND METABOLIC PERFORMANCE
DATA-DRIVEN INSIGHTS: QUANTITATIVE BIOMARKER CHANGES...
What role do diet, obesity, the microbiome, and screening play in early-onset colorectal cancer? Dr Benjamin Levy and Dr Aasma Shaukat discuss the latest evidence.
Rising patient interest in TRT, GLP-1s, and peptide stacking requires clinicians to anchor conversations in evidence tiers, use baseline DEXA scans to monitor body composition, and engage patient goals without endorsing unsupported claims, according to Jean Cunningham, PharmD, BCPS...
* They unpack the myths, the mechanisms, and the real impact behind these breakthrough therapies, and don’t shy away from the harder questions around access, affordability
From Hollywood headlines to hospital hallways, the world’s sudden fascination with GLP-1s makes it hard to separate...
GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, sat down with Jens Juul Holst, MD, DMSc, and Lotte Bjerre Knudsen, DMSc, 2 pioneering scientists behind the discovery and development of...
There are many benefits to maintaining strong metabolic health, including weight management, a strong immune system, and reduced risk for chronic disease. But what does your metabolic health have to do with your sexual health? Ask a Sexpert!
In this video, Dr. Taylor Kohn unpacks the impact of...
Semaglutide, sold as Ozempic and Wegovy, and tirzepatide, sold as Zepbound and Mounjaro, are new therapies for weight loss that actually work, helping millions around the world to feel better. But some people are fearful of side effects, such as loss of muscle mass. Are their fears warranted...
* Dr. le Roux shares exclusive insights into the Phase 3 data for #Survodutide (Boehringer Ingelheim’s dual GLP-1/glucagon agonist), including its groundbreaking impact on visceral fat and #FattyLiverDisease (MASLD/MASH) via the SYNCHRONIZE trials.
In this #DoctorPodcasts Episode 149, we...
Truly impressive!
* the really exciting data of SYNCHRONIZE-1 was not the weight loss it was actually the metabolic health gains so we see that there was an improvement in glycemia and blood pressure but there was a. 63% REDUCTION IN FAT IN THE LIVER so imagine you had 16% weight loss but 25%...
Carel le Roux is a Professor of Experimental Pathology at University College Dublin, Director of the Metabolic Medicine Group, and one of the world's leading researchers on how the gut communicates with the brain. He completed his PhD at Imperial College London, where he conducted foundational...
Nature staff discuss preliminary data on the effects of GLP-1 drugs on male fertility, plus a two-year trial of a brain-computer interface.
Timestamps
00:18 Brain-computer interface makes a life-changing impactNature: At-home brain implant gives man with motor neuron disease his daily life...
Dr. Andres Guillen Lozoya discusses findings from, "Testosterone Levels Improve in Men under GLP-1 Receptor Agonist Therapy.” This study aimed to evaluate changes in total and free testosterone before and after GLP-1RA therapy in men
In this episode of Science Quickly, Scientific American’s associate health editor Lauren Young joins host Kendra Pierre-Louis to talk about how the story of GLP‑1 drugs such as Ozempic, Wegovy and Mounjaro is evolving. We trace GLP-1s’ origins as type 2 diabetes treatments, their rise as...
Are GLP-1 agonists like Ozempic and Mounjaro the future of healthcare or a risk to your health? We break down the latest data on weight loss medication efficacy, common side effects, and the truth about muscle mass loss (sarcopenia).
In This Episode:
Dr. Jordan Feigenbaum and Dr. Austin...
In this video, David Kerr, MD examines the complex relationship between GLP-1 receptor agonists and gastrointestinal health. While these agents are highly effective for treating type 2 diabetes and obesity, a large-scale meta-analysis of over five million individuals suggests a nuanced...
Dr. Corona another powerhouse in the field!
* The current video summarizes and critical analyzes available evidence from the first reports to a recently updated meta-analysis [1]. Data derived from a meta-analytic approach, including 25 studies and 18,237 subjects showed that MetS was...
In this SCCR Science Series session, Elaine Costa, MD, a postdoctoral scholar in the Department of Otolaryngology, Head, and Neck Surgery (OHNS) provides an overview of obstructive sleep apnea (OSA).
Here she covers:
Professor Michael Zitzmann
Testosterone Deficiency (TD). and its Effects
https://www.excelmale.com/threads/the-male-hormone-reset-how-glp-1ras-lifestyle-and-testosterone-transform-obesity-linked-problems.33386/
What actually makes a GLP-1 pill work in the real world—and why does taking it come with such specific rules? And if these meds improve health beyond weight, why does the conversation still get stuck on the scale?Dr. Emily Cooper, Mark Wright, and Andrea Taylor sit down with Novo Nordisk’s Dr...
Dr. Peter Wilson
I am going to give you some pearls from recent talks.
1:28-2:19
* Shehzad Basaria from Harvard who's on the TRAVERSE Trial. He said one of the biggest mistakes were making is assuming free testosterone is correct. Thats important and I think we in endocrinology and urology...
Think sleep apnea is just for "middle-aged men who snore?" Think again. Dr. Kimberly Sterling and Dr. Audrey Wells join us to reveal why 90% of women are living with undiagnosed sleep apnea and how "invisible" symptoms like fatigue and anxiety are masking a life-threatening breathing disorder.